CGEN logo

Compugen Ltd. (CGEN)

Profile

Full Name

Compugen Ltd.

Ticker

NASDAQ: CGEN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

August 11, 2000

Indexes

Not included

Website

https://cgen.com

Employees

74

Key Details

Price

$1.52(-0.65%)

Market Cap

$142.17M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$27.86M(-16.72% YoY)

Annual EPS

-$0.16(25.70% YoY)

PE Ratio

-

Next earnings date

Mar 3, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.52
    CGEN price is $1.52

    30-Day Relative Volume

    0.39
    CGEN 30-day relative volume is 0.39

    Price Performance

    Price Most Recent Change

    -0.65%
    CGEN price was down -0.65% on Dec 23, 2025

    Price YTD Change

    -0.65%
    CGEN price is down -0.65% since January 1st

    Price 1-Year Change

    0%
    CGEN price has remained unchanged year-on-year

    Price 3-Year Change

    +100%
    CGEN price is up +100% over the past 3 years

    Price Range

    Price All-Time High

    $19.90
    CGEN price is currently -92.36% below its historical high of $19.90

    Price 3-Year Low

    $0.53
    CGEN price is currently +186.79% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $142.17M
    CGEN market cap is $142.17 million

    Market Cap 3-Year Change

    +115.96%
    CGEN market cap is up +115.96% over the past 3 years

    Market Cap All-Time High

    $1.61B
    CGEN market cap is currently -91.16% below its historical high of $1.61 billion

    Market Cap Sector Percentile

    44.69%
    CGEN market cap is higher than 44.69% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +4.47%
    CGEN shares outstanding is up +4.47% year-on-year

    Shares Outstanding 3-Year Change

    +7.98%
    CGEN shares outstanding is up +7.98% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.27
    CGEN beta is 1.27

    200-day SMA

    $1.55
    CGEN price is currently -1.78% below its 200-day simple moving average

    50-day SMA

    $1.65
    CGEN price is currently -7.71% below its 50-day simple moving average

    14-Day RSI

    45.29
    CGEN 14-day relative strength index is 45.29

    Volume

    0.39
    CGEN 30-day relative volume is 0.39

    ATR

    $0.09
    CGEN average true range is $0.09

    10-day Historical Volatility

    27.91%
    CGEN 10-day historical volatility is 27.91%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $27.86M
    CGEN annual revenue is $27.86 million

    Revenue Analysts Estimate

    $6.77M
    CGEN annual revenue is currently +311.78% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    -16.72%
    CGEN annual revenue is down -16.72% year-on-year

    Revenue Sector Percentile

    55.55%
    CGEN annual revenue is higher than 55.55% of companies in Healthcare sector

    EPS

    EPS

    -$0.16
    CGEN annual earnings per share is -$0.16

    EPS Analysts Estimate

    -$0.30
    CGEN annual earnings per share is currently +47.87% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +25.7%
    CGEN annual earnings per share is up +25.7% year-on-year

    EPS Sector Percentile

    76.13%
    CGEN annual earnings per share is higher than 76.13% of companies in Healthcare sector

    Profit

    Gross Profit

    $19.93M
    CGEN annual gross profit is $19.93 million

    Gross Margin

    71.54%
    CGEN annual gross profit margin is 71.54%

    Operating Profit

    -$14.89M
    CGEN annual operating income is -$14.89 million

    Operating Margin

    -53.44%
    CGEN annual operating profit margin is -53.44%

    Net Income

    -$14.23M
    CGEN annual net profit is -$14.23 million

    Net Margin

    -51.07%
    CGEN annual net profit margin is -51.07%

    Expenses

    Total Expenses

    $42.76M
    CGEN annual total expenses is $42.76 million

    Operating Expenses

    $34.83M
    CGEN annual total operating expenses is $34.83 million

    Cost Of Goods Sold

    $7.93M
    CGEN annual cost of goods sold is $7.93 million

    Selling, General & Administrative Expenses

    $10.02M
    CGEN annual SG&A is $10.02 million

    Depreciation & Amortization

    $486.00K
    CGEN annual D&A is $486.00 thousand

    Interest Expense

    $0.00
    CGEN annual interest expense is $0.00

    Income Tax

    $4.52M
    CGEN annual income tax is $4.52 million

    EBIT & EBITDA

    EBIT

    -$14.89M
    CGEN annual earnings before interest & taxes is -$14.89 million

    EBITDA

    -$14.40M
    CGEN annual EBITDA is -$14.40 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $115.00M
    CGEN annual total assets is $115.00 million

    Non Current Assets

    $9.00M
    CGEN annual long term assets is $9.00 million

    Current Assets

    $106.00M
    CGEN annual total current assets is $106.00 million

    Cash and Cash Equivalents

    $18.23M
    CGEN annual cash & cash equivalents is $18.23 million

    Accounts Receivable

    $0.00
    CGEN annual accounts receivable is $0.00

    Inventory

    $0.00
    CGEN annual inventory is $0.00

    Liabilities

    Total Liabilities

    $60.08M
    CGEN annual total liabilities is $60.08 million

    Long Term Liabilities

    $39.92M
    CGEN annual total long term liabilities is $39.92 million

    Current Liabilities

    $20.16M
    CGEN annual current liabilities is $20.16 million

    Accounts Payable

    $1.84M
    CGEN annual accounts payable is $1.84 million

    Debt

    Total Debt

    $2.91M
    CGEN annual total debt is $2.91 million

    Total Debt 1-Year Change

    +115.54%
    CGEN annual total debt is up +115.54% year-on-year

    Long Term Debt

    $2.46M
    CGEN annual long term debt is $2.46 million

    Short Term Debt

    $448.00K
    CGEN annual short term debt is $448.00 thousand

    Equity & Capital

    Shareholders Equity

    $54.91M
    CGEN annual stockholders equity is $54.91 million

    Book Value

    $54.91M
    CGEN annual book value is $54.91 million

    Retained Earnings

    -$488.76M
    CGEN annual retained earnings is -$488.76 million

    Working Capital

    $85.84M
    CGEN annual working capital is $85.84 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $49.60M
    CGEN annual cash from operations is $49.60 million

    Cash From Operations 1-Year Change

    +238.23%
    CGEN annual cash from operations is up +238.23% year-on-year

    Cash From Investing

    -$46.25M
    CGEN annual cash from investing is -$46.25 million

    Cash From Investing 1-Year Change

    -230.25%
    CGEN annual cash from investing is down -230.25% year-on-year

    Cash From Financing

    $554.00K
    CGEN annual cash from financing is $554.00 thousand

    Cash From Financing 1-Year Change

    -82.02%
    CGEN annual cash from financing is down -82.02% year-on-year

    CAPEX

    CAPEX

    $118.00K
    CGEN annual capital expenditures is $118.00 thousand

    CAPEX 1-Year Change

    -31.4%
    CGEN annual capital expenditures is down -31.4% year-on-year

    Free Cash Flow

    Free Cash Flow

    $49.49M
    CGEN annual free cash flow is $49.49 million

    Free Cash Flow 1-Year Change

    +237.24%
    CGEN annual free cash flow is up +237.24% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    71.54%
    CGEN annual gross profit margin is 71.54%

    Operating Margin

    -53.44%
    CGEN annual operating profit margin is -53.44%

    Net Margin

    -51.07%
    CGEN annual net profit margin is -51.07%

    ROA & ROE

    ROA

    -12.04%
    CGEN annual return on assets is -12.04%

    ROE

    -23.63%
    CGEN annual return on equity is -23.63%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    CGEN price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    CGEN price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    3.24
    CGEN price to book ratio is 3.24

    PB Ratio Sector Percentile

    63.95%
    CGEN price to book ratio is higher than 63.95% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    20.60
    CGEN price to sales ratio is 20.60

    PS Ratio Sector Percentile

    79.9%
    CGEN price to sales ratio is higher than 79.9% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $59.03M
    CGEN enterprise value is $59.03 million

    Enterprise Value Sector Percentile

    37.78%
    CGEN enterprise value is higher than 37.78% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    CGEN EV/EBITDA value is unknown

    EV/EBITDA Sector Percentile

    -
    CGEN EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    5.26
    CGEN annual current ratio is 5.26

    Quick Ratio

    5.26
    CGEN annual quick ratio is 5.26

    Leverage

    Debt To Equity

    0.00
    CGEN annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    CGEN annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    CGEN piotroski f-score value is unknown

    Altman Z-Score

    -3.82
    CGEN altman z-score is -3.82

    Analyst ratings

    Recent major analysts updates

    May 21, 24 Truist Securities
    Buy
    Mar 8, 24 Truist Securities
    Buy
    Dec 19, 23 Stifel
    Buy
    Aug 23, 23 Truist Securities
    Buy
    Aug 7, 23 EF Hutton
    Buy
    Jun 6, 23 EF Hutton
    Buy
    May 26, 23 EF Hutton
    Buy
    May 24, 23 EF Hutton
    Buy
    May 16, 23 Oppenheimer
    Outperform
    Feb 28, 23 Oppenheimer
    Outperform

    Institutional Ownership

    Screeners with CGEN included

    Growing Shares Outstanding
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    NASDAQ Listed Companies
    • What is the ticker symbol for Compugen Ltd.?
    • Does Compugen Ltd. pay dividends?
    • What sector is Compugen Ltd. in?
    • What industry is Compugen Ltd. in?
    • What country is Compugen Ltd. based in?
    • When did Compugen Ltd. go public?
    • Is Compugen Ltd. in the S&P 500?
    • Is Compugen Ltd. in the NASDAQ 100?
    • Is Compugen Ltd. in the Dow Jones?
    • When was Compugen Ltd.'s last earnings report?
    • When does Compugen Ltd. report earnings?

    What is the ticker symbol for Compugen Ltd.?

    The ticker symbol for Compugen Ltd. is NASDAQ:CGEN

    Does Compugen Ltd. pay dividends?

    No, Compugen Ltd. does not pay dividends

    What sector is Compugen Ltd. in?

    Compugen Ltd. is in the Healthcare sector

    What industry is Compugen Ltd. in?

    Compugen Ltd. is in the Biotechnology industry

    What country is Compugen Ltd. based in?

    Compugen Ltd. is headquartered in Israel

    When did Compugen Ltd. go public?

    Compugen Ltd.'s initial public offering (IPO) was on August 11, 2000

    Is Compugen Ltd. in the S&P 500?

    No, Compugen Ltd. is not included in the S&P 500 index

    Is Compugen Ltd. in the NASDAQ 100?

    No, Compugen Ltd. is not included in the NASDAQ 100 index

    Is Compugen Ltd. in the Dow Jones?

    No, Compugen Ltd. is not included in the Dow Jones index

    When was Compugen Ltd.'s last earnings report?

    Compugen Ltd.'s most recent earnings report was on November 10, 2025

    When does Compugen Ltd. report earnings?

    The next expected earnings date for Compugen Ltd. is March 3, 2026
    On this page